Trial · NCT07890623
EVS With Exercise for Balance With Older Adults
NCT07890623, Not applicable, Not yet recruiting, University of Calgary
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. EVS With Exercise for Balance With Older Adults. Trials, record NCT07890623. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890623
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- EVS With Exercise for Balance With Older Adults
- NCT number
- NCT07890623
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 150 participants, estimated
- Lead sponsor
- University of Calgary
- Conditions
- Gait Balance
- Interventions
- Noisy electrical vestibular stimulation, Sham device
- First posted
- 2026-10-22
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Phybrata power | At the start of the 6-week intervention (week 0), midpoint (week 3), and end of the 6-week intervention (week 6) | Change in Phybrata power from pretreatment to completion of the 6-week course, calculated from head-mounted accelerometers recording a 60-second standing assessment under different standing balance conditions (mCTSIB; floor yes open, floor eyes closed, compliant surface eyes open, compliant surface eyes closed). Values are expressed in watts taking the sum of the squared acceleration of the tri-axial accelerometer multiplied by a time scaling factor. Lower values indicate less sway, a negative change indicates improved performance. The primary comparison is active vs sham nEVS, adjusted for pretreatment performance. |
| Secondary | Gait speed | At the start of the 6-week intervention (week 0), midpoint (week 3), and end of the 6-week intervention (week 6) | Change in overground gait speed in metres per second over a 25-foot course. Speed equals distance divided by walking time. Higher values indicate faster walking. |
| Secondary | Timed-up-and-go | At the start of the 6-week intervention (week 0), midpoint (week 3), and end of the 6-week intervention (week 6) | Change in time, in seconds, to stand from a chair, walk 3 metres at a self selected pace, turn, return to the chair, and sit. Usual walking aids are permitted and recorded. Lower completion time indicates faster functional mobility. |
| Secondary | Short Physical Performance Battery total score | At the start of the 6-week intervention (week 0), midpoint (week 3), and end of the 6-week intervention (week 6) | Change in short physical performance battery (SPPB) total score. Standardized standing balance, usual-pace walking, and repeated chair0rise components contribute 0-4 points, giving a total score from 0-12. Higher scores indicate better physical performance. |
| Secondary | Grip strength | At the start of the 6-week intervention (week 0), midpoint (week 3), and end of the 6-week intervention (week 6) | Change in hand-grip strength in kilograms, measured using acalibrated hand dynameter in a standardized seated position. Two valid attempts are recorded. The participants best score is used for analysis. Higher values indicate greater grip strength. |
| Secondary | PROMIS Global Physical Health Score | Immediately before the first EVS or sham session and at completion of the six-week course. | Change in physical health assessed using the PROMIS Global Health v1.2 questionnaire. The four-item physical health raw score will be converted to a T-score using the official scoring tables. T-scores range from 16.2 to 67.7, with higher scores indicating better physical health. Change will be calculated as the end-of-course score minus the pretreatment score; positive values indicate improvement |
| Secondary | PROMIS Global Mental Health Score | Immediately before the first EVS or sham session and at completion of the six-week course. | Change in mental health assessed using the PROMIS Global Health v1.2 questionnaire. The four-item mental health raw score will be converted to a T-score using the official scoring tables. T-scores range from 21.2 to 67.6, with higher scores indicating better mental health. Change will be calculated as the end-of-course score minus the pretreatment score; positive values indicate improvement. |
| Secondary | Distribution of EQ 5D 5L Mobility Response Levels | Immediately before the first EVS or sham session and at completion of the six-week course. | Number and percentage of participants in each response level of the EQ-5D-5L mobility dimension at each assessment. The dimension concerns walking about. Levels range from 1 to 5, with level 1 indicating no problems and level 5 the most severe problems or inability. Lower levels indicate fewer problems. Each dimension is reported separately. |
| Secondary | Distribution of EQ 5D 5L Self Care Response Levels | Immediately before the first EVS or sham session and at completion of the six-week course | Number and percentage of participants in each response level of the EQ-5D-5L self care dimension at each assessment. The dimension concerns washing or dressing. Levels range from 1 to 5, with level 1 indicating no problems and level 5 the most severe problems or inability. Lower levels indicate fewer problems. Each dimension is reported separately. |
| Secondary | Distribution of EQ 5D 5L Usual Activities Response Levels | Immediately before the first EVS or sham session and at completion of the six-week course | Number and percentage of participants in each response level of the EQ-5D-5L usual activities dimension at each assessment. The dimension concerns usual daily activities. Levels range from 1 to 5, with level 1 indicating no problems and level 5 the most severe problems or inability. Lower levels indicate fewer problems. Each dimension is reported separately. |
1 to 10 of 20Source ClinicalTrials.gov
See all 20 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Symbol Scan Task | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07890623
GET https://conductscience.org/api/trials/v1/NCT07890623/registered